# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Nikola Tesla (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI009-SYN
- Date: 2026-01-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Branimir Kovač-Holt, MD
- Calendar frame: modern shifted

## Subjective

The patient participates in this fictional visit for new-patient primary care visit for counting, washing, and food rituals that are taking hours each day, with weight loss and sore hands. **S**

## Objective

PHQ-9: 8; GAD-7: 12; AUDIT-C: 1; Sodium: 138 mmol/L; Potassium: 4.1 mmol/L; Bicarbonate (total CO2): 25 mmol/L; BUN: 11 mg/dL; Creatinine: 0.82 mg/dL; eGFR: 110 mL/min/1.73 m²; Glucose: 81 mg/dL; Albumin: 3.8 g/dL; Hemoglobin: 13.4 g/dL; TSH: 2.2 mIU/L; Vitamin B12: 284 pg/mL. All results are synthetic.

BP 116/72 mmHg; pulse 74 bpm; respirations 14/min; temperature 36.5 °C; oxygen saturation 99% on room air; weight 63.8 kg; BMI 18.1 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Obsessive-compulsive disorder, severe (Y-BOCS 28), with good insight: contamination, symmetry, and number obsessions; washing, counting, repeating in threes, and calculating compulsions; synthetic modern diagnosis linked to his own accounts of counting and calculating rituals and aversions; Irritant contact dermatitis of both hands from washing them 40 to 60 times a day; Underweight (BMI 18.1) with about 4 kg weight loss over six months, from skipped meals and food-calculating rituals; Insufficient sleep, four hours a night, from late work and night-time rituals. Strengths and supports remain part of the care plan. **S**

## Medication changes

- Started: Sertraline 50 mg oral tablet, one tablet by mouth each morning **S**
- Started: White petrolatum ointment, apply to both hands after each wash and at bedtime **S**

## Plan

- Structured assessment: Y-BOCS symptom checklist and severity scale, PHQ-9, GAD-7, and AUDIT-C today; interview for tics, bipolar disorder, psychosis, hoarding, and body dysmorphic symptoms; thyroid, blood count, metabolic panel, albumin, and vitamin B12 for weight loss. Guideline: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007); Guideline Watch: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2013); Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005) **S**
- Psychiatry consultation to confirm the diagnosis, review comorbidity, and advise on sertraline dosing and the length of the trial. Guideline: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007); Guideline Watch: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2013); Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005) **S**
- Exposure and response prevention with the clinic psychologist, weekly for 16 to 20 sessions, with a hierarchy he builds himself (touching door handles, shaking hands, eating without calculating, doing things in numbers other than three) and homework between sessions. Guideline: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007); Guideline Watch: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2013); Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005) **S**
- Start sertraline 50 mg each morning; if the response is inadequate after four to six weeks, raise it in 50 mg steps every four to six weeks as tolerated, up to 200 mg, warning him about side effects and checking for them after each increase; judge the response only after eight to twelve weeks with at least four to six weeks at the top tolerated dose; continue for one to two years after a response. Guideline: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007); Guideline Watch: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2013); Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005) **S**
- Collaborative safety plan with warning signs, coping steps, people to contact, the clinic number, and the 988 Suicide & Crisis Lifeline; suicide-risk review at every visit. Guideline: VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**
- Nutrition: three fixed mealtimes, energy-dense foods he accepts, a session with the clinic dietitian, and weight at every visit; eating without calculating is an exposure target, not a rule imposed at the table. Guideline: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007); Guideline Watch: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2013); Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005) **S**
- Hands: petrolatum after each wash and at night, cotton gloves overnight, nitrile gloves for laboratory solvents; cutting down washing is part of the exposure work. Guideline: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007); Guideline Watch: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2013); Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005) **S**
- Sleep: a fixed six-to-seven-hour sleep window, no laboratory work after midnight, and a sleep diary. Guideline: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007); Guideline Watch: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2013); Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005) **S**
- Respectful examination: explain each step and ask before touching; offer hand sanitizer, gloves, and paper covers before and after; let him wash if he wishes; no handshake expected; no unplanned exposures in clinic, which belong in therapy. Guideline: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007); Guideline Watch: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2013); Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005) **S**
